Management of axillary staging in breast cancer patients treated with neoadjuvant chemotherapy

By Sbaity Eman   Cody Hiram S  

Breast Cancer Management, Vol. 2, Iss. 6, 2013-11 ,pp. : 499-505

Future Medicine

Access to resources Recommend Favorite

Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRI

By Cheung Y-C.  

Breast Cancer Research and Treatment, Vol. 78, Iss. 1, 2003-03 ,pp. : 51-58

Springer Publishing Company

Access to resources Recommend Favorite

The value of platinum agents as neoadjuvant chemotherapy in triple-negative breast cancers: a systematic review and meta-analysis

By Petrelli Fausto   Coinu Andrea   Borgonovo Karen   Cabiddu Mary   Ghilardi Mara   Lonati Veronica   Barni Sandro  

Breast Cancer Research and Treatment, Vol. 144, Iss. 2, 2014-04 ,pp. : 223-232

Springer Publishing Company

Access to resources Recommend Favorite

Predictive value of tumour cell proliferation in locally advanced breast cancer treated with neoadjuvant chemotherapy

By Aas T.   Geisler S.   Eide G.E.   Haugen D.F.   Varhaug J.E.   Bassoe A.M.   Thorsen T.   Berntsen H.   Borresen-Dale A.-L.   Akslen L.A.   Lonning P.E.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 438-446

Elsevier

Access to resources Recommend Favorite

Clinical significance of Smac and survivin expression in breast cancer patients treated with anthracyclinebased neoadjuvant chemotherapy

By              

Molecular Medicine Reports, Vol. 9, Iss. 2, 2014-01 ,pp. : 614-620

Spandidos Publications

Access to resources Recommend Favorite